Načítá se...
Phase I and II Clinical Trial Comparing the LBSap, Leishmune(®), and Leish-Tec(®) Vaccines against Canine Visceral Leishmaniasis
In this study, we performed a phase I and II clinical trial in dogs to evaluate the toxicity and immunogenicity of LBSap-vaccine prototype, in comparison to Leishmune(®) and Leish-Tec(®) vaccines. Twenty-eight dogs were classified in four groups: (i) control group received 1 mL of sterile 0.9% salin...
Uloženo v:
| Vydáno v: | Vaccines (Basel) |
|---|---|
| Hlavní autoři: | , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
MDPI
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7712644/ https://ncbi.nlm.nih.gov/pubmed/33212786 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/vaccines8040690 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|